ДЕНЬ МУКОВИСЦИДОЗА В РОССИИ
Список литературы
1. URL: http://www.rd.com/slideshows/news-from-the-world-ofmedicine/#ixzz3Q7BKlVDw
2. Iliodromiti S., Mackay D. F., Smith G. C. et al. Apgar score and the risk of cause-specific infant mortality: a population-based cohort study. Lancet. 2014; 384: 1749.
3. Lacro R. V., Dietz H. C., Sleeper L. A. et al. Atenolol versus losartan in children and young adults with Marfan’s syndrome. N Engl J Med. 2014; 371: 2061.
4. Vriezinga S. L., Auricchio R., Bravi E. et al. Randomized feeding intervention in infants at high risk for celiac disease. N Engl J Med.2014; 371: 1304.
5. Lionetti E., Castellaneta S., Francavilla R. et al. Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med. 2014; 371: 1295.
6. Rowe S. M., Heltshe S. L., Gonska T. et al. Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis. Am J Respir Crit Care Med. 2014; 190: 175.
Рецензия
Для цитирования:
ДЕНЬ МУКОВИСЦИДОЗА В РОССИИ. Педиатрическая фармакология. 2015;12(1):15-17.
For citation:
MEDICAL NEWS. Pediatric pharmacology. 2015;12(1):15-17.